問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2022-05-01 - 2023-02-23
Condition/Disease
Test Drug
Participate Sites2Sites
Recruiting2Sites
2023-05-31 - 2027-09-30
Participate Sites5Sites
Recruiting5Sites
2023-11-01 - 2028-12-31
Participate Sites8Sites
Recruiting8Sites
2023-10-20 - 2026-12-31
B-cell Non Hodgkin Lymphoma、 Diffuse Large B Cell Lymphoma 、High-grade B-cell Lymphoma、 Follicular Lymphoma
AZD0486
Participate Sites4Sites
Recruiting4Sites
2020-12-14 - 2025-07-28
Non- Small Cell Lung Cancer
DS-1062a
2020-11-01 - 2024-07-22
2021-08-15 - 2024-12-31
2021-04-30 - 2025-09-30
Participate Sites7Sites
Recruiting7Sites
2021-05-01 - 2023-10-18
2020-09-15 - 2025-10-08
Non-Small Cell Lung Cancer (NSCLC)
Patritumab Deruxtecan (U3-1402)
全部
